DAMORA THERAPEUTICS INC (DMRA) Stock Income Statement
NASDAQ:DMRA • US36322Q2066
Current stock price
21.99 USD
-1.06 (-4.6%)
Last:
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.88M | 16.90M | 36.46M | 61.21M | 52.23M | |||
| Research and Development | 4.57M | 6.40M | 23.77M | 48.21M | 38.49M | |||
| Selling, General, and Administrative Expenses | 7.32M | 10.50M | 12.69M | 13.00M | 13.74M | |||
| Operating Income | -11.88M | -16.90M | -36.46M | -61.21M | -52.23M | |||
| Interest Income/Expense | 432.00K | 862.00K | 1.49M | -420.00K | 480.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | -5.36M | -3.45M | N/A | N/A | |||
| Income Before Taxes | -15.85M | -21.40M | -38.35M | -61.62M | -51.75M | |||
| Income Tax | -2.00K | 41.00K | N/A | N/A | N/A | |||
| Net Income | -15.84M | -21.44M | -38.35M | -61.62M | -51.75M | |||
| EBITDA | -12.08M | -16.88M | -36.19M | -61.17M | -52.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -12.01 | -18.53 | -36.08 | -2.43 | -2.05 | |||
| Non GAAP EPS | N/A | -17.62 | -36.50 | N/A | -51.25 | |||
| Statistics | ||||||||
All data in USD